¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå : Á¦Ç° À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº° ¹× Áö¿ªº°
West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region
»óǰÄÚµå : 1402588
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2023³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,333,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,852,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,075,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå ±Ô¸ð´Â 2023³â 6¾ï 3,480¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 10¾ï 9,780¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 8.1%·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â ½ÃÀå ±Ô¸ð(2023³â) 6¾ï 3,480¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023-2030³â
¿¹Ãø ±â°£ÀÇ CAGR 8.10% ½ÃÀå ±Ô¸ð ¿¹Ãø(2030³â) 10¾ï 9,780¸¸ ´Þ·¯
±×¸² 1. ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå Áö¿ªº° Á¡À¯À²(%)(2023³â)
West Nile Virus Market-IMG1

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º(WNV)´Â ¸ð±â°¡ ¸Å°³ÇÏ´Â Áúº´À¸·Î Àΰ£, Á¶·ù ¹× ±âŸ µ¿¹°À» °¨¿°½Ãŵ´Ï´Ù. 1937³â ¿ì°£´ÙÀÇ ¿þ½ºÆ® ³ªÀÏ Áö¿ª¿¡¼­ óÀ½À¸·Î È®ÀÎµÈ ÀÌ·¡ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ µî ¼¼°è °¢Áö¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º´Â ÁÖ·Î °¨¿°µÈ ¸ð±â¿¡ ¹°·Á¼­ »ç¶÷¿¡°Ô °¨¿°µË´Ï´Ù. WNV´Â °¡º­¿î ÀÎÇ÷翣ÀÚ¿Í °°Àº Áõ»ó¿¡¼­ºÎÅÍ ³ú¿°°ú ¼ö¸·¿°°ú °°Àº ½É°¢ÇÑ ½Å°æ Áúȯ¿¡ À̸£±â±îÁö ´Ù¾çÇÑ Áõ»óÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ëºÎºÐÀÇ °¨¿°ÀÚ´Â ¾î¶² Áõ»óµµ ³ªÅ¸³ªÁö ¾ÊÁö¸¸, ¾à 20%´Â ¹ß¿­, µÎÅë, ½Åü ÅëÁõ, ¸Þ½º²¨¿ò, ±¸Åä, ¹ßÁøÀ» °æÇèÇÒ ¼ö ÀÖ½À´Ï´Ù. µå¹°°Ô WNV´Â Á×À½À¸·Î À̾îÁö´Â °æ¿ìµµ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀº ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì¿Í À¯·´¿¡¼­ WNV °¨¿°ÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ Áúº´°ú ±× ¿¹¹æ, Áø´Ü¿¡ ´ëÇÑ ÀǽÄÀÇ °íÁ¶µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Áúº´ ¿¹¹æ °ü¸® ¼¾ÅÍ(CDC)ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, Àü±¹ °¨½Ã ½Ã½ºÅÛ¿¡ º¸°íµÈ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½Å°æÄ§½À¼º Áúȯ »ç·Ê ¼ö´Â 2021³â 2000¸í À̻󿡼­ 2022³â 2500¸í ÀÌ»óÀ¸·Î Áõ°¡Çß½À´Ï´Ù. ÅØ»ç½ºÁÖ, ͏®Æ÷´Ï¾ÆÁÖ, ·çÀÌÁö¾Ö³ªÁÖ, ³×ºê¶ó½ºÄ«ÁÖ, Àϸ®³ëÀÌÁÖ µîÀÇ ÁÖ°¡ °¡Àå »ç·Ê ¼ö°¡ ¸¹½À´Ï´Ù. ¹ÙÀÌ·¯½ºÀÇ À¯ÇàÀÌ È®´ëµÇ°í ÀÖ´Â ÀÌÀ¯´Â ±âÈÄ º¯È­¿¡ µû¸¥ ±â¿ÂÀÇ »ó½Â¿¡ ÀÇÇØ °¨¿° ½ÃÁðÀÌ ¿¬ÀåµÇ°í ¹ÙÀÌ·¯½º¸¦ È®»ê½ÃŰ´Â ¸ð±âÀÇ Áö¸®Àû ¹üÀ§°¡ È®´ëµÇ°í Àֱ⠶§¹®À̶ó°í »ý°¢µË´Ï´Ù.

±×·¯³ª ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÏ´Â ¿äÀεµ ÀÖ½À´Ï´Ù. È¿°úÀûÀÎ Ä¡·á¹ý°ú ¹é½ÅÀÌ Á¦ÇѵǾî ÀÖ´Â °ÍÀÌ WNV ´ëÃ¥¿¡¼­ Å« °úÁ¦ÀÔ´Ï´Ù. Áø´Ü ¹× Ä¡·á¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸Çϰí, ½ÃÀå ÁøÃâ±â¾÷Àº Ȱ·Î¸¦ ãÀ» ±âȸ°¡ ÀÖ½À´Ï´Ù. ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ ³ôÀº ¼ºÀå ÀáÀç·Â, È¿°úÀûÀÎ Ä¡·á¹ý °³¹ß ¹× ¸ð±â Á¦°Å ¹æ¹ýÀÇ È°¿ë·üÀÌ Áõ°¡ÇÏ¸é ¼ºÀåÀÇ Å« ±âȸ°¡ µË´Ï´Ù. ¶ÇÇÑ Á¦¾à±â¾÷ ¹× ¿¬±¸±â°üÀÇ Çù·ÂÀ¸·Î WNV¿¡ ´ëÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ßÀÌ °¡¼ÓÈ­µÉ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦ Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Äڷγª¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Á¦Ç° À¯Çüº°(2018-2030³â)

Á¦6Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Åõ¿© °æ·Îº°(2018-2030³â)

Á¦7Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-À¯Åë ä³Îº°(2018-2030³â)

Á¦8Àå ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-Áö¿ªº°(2018-2030³â)

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¼½¼Ç

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The West Nile virus market size is expected to reach US$$ 1,097.8 Mn by 2030, from US$ 634.8 million in 2023, at a CAGR of 8.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 634.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 1,097.8 Mn
Figure 1. Global West Nile Virus Market Share (%), by Region, 2023
West Nile Virus Market - IMG1

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.

Market Dynamics:

The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.

However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.

Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2018-2030, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2018-2030, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2018-2030, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2018-2030, (US$ Mn)

9. Competitive Landscape

10. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â